Protocol Library

Each card lists peptide research notes — vial size, example research dose range, reconstitution example, frequency example, cycle length example, and risk level. All entries are educational. Not medical advice.

Research use only. Educational content. Not medical advice, diagnosis, treatment, or a personal recommendation. Not intended for human consumption. Always discuss with a qualified healthcare professional.

BPC-157

low risk

Commonly researched for tendon, ligament, gut lining and wound repair contexts.

Vial: 5 mg
Dose: 200–500 mcg daily (research literature)
Freq: 1–2x daily (research example)
Cycle: 4–8 weeks (research example)

recoverygut-healthjoint

Cartalax

low risk

Commonly researched for cartilage, connective-tissue and joint research models.

Vial: 20 mg
Dose: Research literature commonly references 100–200 mcg per research day.
Freq: Once daily in research scheduling examples.
Cycle: 10–20 days per research cycle, often repeated 2–3 times per year in published bioregulator protocols.

jointbioregulatorsrecovery

GLOW Blend (BPC-157 + TB-500 + GHK-Cu)

moderate risk

Studied as a combined research peptide profile for repair-related endpoints.

Vial: Blend vial (varies by source)
Dose: Educational research dose example only.
Freq: Daily or alternating-day research designs.
Cycle: 4–8 week educational example.

recoveryskin-hairjoint

TB-500

moderate risk

Researched in soft tissue, muscle, and vascular repair contexts.

Vial: 5 mg
Dose: 2–5 mg weekly (research literature)
Freq: 1–2x weekly (research example)
Cycle: 4–6 weeks (research example)

recoveryjoint

Verified Research Supplier

Looking for a research supplier?

Enhanced Performance is a separate research supply platform. Visiting or purchasing is optional and not required to use PepToolbox.

Visit Enhanced Performance

Disclosure: Enhanced Performance is a separate platform connected to the owner of this website. Purchasing is optional and not required to use this tool.